Float Short %

0.11

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

0.19

Price

Target Price

2.67

Analyst Recom

Performance Q

-45.29

Relative Volume

Beta

1.07

Ticker: VJET

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-10	VJET	0.6401	N/A	N/A	0
2025-11-11	VJET	0.6401	N/A	N/A	0
2025-11-12	VJET	0.6401	N/A	N/A	0
2025-11-13	VJET	0.6401	N/A	N/A	0
2025-11-14	VJET	0.6401	N/A	N/A	0
2025-11-17	VJET	0.6401	N/A	N/A	0
2025-11-18	VJET	0.6401	N/A	N/A	0
2025-11-19	VJET	0.6401	N/A	N/A	0
2025-11-20	VJET	0.6401	N/A	N/A	0
2025-11-21	VJET	0.6401	N/A	N/A	0
2025-11-24	VJET	0.6401	N/A	N/A	0
2025-11-25	VJET	0.6401	N/A	N/A	0
2025-11-26	VJET	0.6401	N/A	N/A	0
2025-12-01	VJET	0.6401	N/A	N/A	0
2025-12-02	VJET	0.6401	N/A	N/A	0
2025-12-03	VJET	0.6401	N/A	N/A	0
2025-12-04	VJET	0.6401	N/A	N/A	0
2025-12-05	VJET	0.6401	N/A	N/A	0
2025-12-08	VJET	0.6401	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

-0.49

Avg. EPS Est. Next Quarter

-0.3

Insider Transactions

Institutional Transactions

80.2

Beta

1.07

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

97.5

Max Drawdown 5-Year %

-98.7

Target Price

2.67

P/E

Forward P/E

PEG

P/S

0.18

P/B

0.38

P/Free Cash Flow

EPS

-1.2

Average EPS Est. Cur. Y

-1.62

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-34.59

Relative Volume

Return on Equity vs Sector %

-119.2

Return on Equity vs Industry %

-106.7

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

stock quote shares VJET – Voxeljet AG ADR Stock Price stock today

news today VJET – Voxeljet AG ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch VJET – Voxeljet AG ADR yahoo finance google finance

stock history VJET – Voxeljet AG ADR invest stock market

stock prices VJET premarket after hours

ticker VJET fair value insiders trading

Float Short %

5.86

Margin Of Safety %

Put/Call OI Ratio

0.03

EPS Next Q Diff

0.04

EPS Last/This Y

-2.13

EPS This/Next Y

0.13

Price

10.28

Target Price

18.37

Analyst Recom

Performance Q

77.55

Relative Volume

0.8

Beta

1.36

Ticker: IMTX

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-10	IMTX	9.01	0.00	0.00	18429
2025-11-11	IMTX	9.19	0.00	0.00	18429
2025-11-12	IMTX	10.68	0.00	0.00	18429
2025-11-13	IMTX	9.98	0.00	0.00	18425
2025-11-14	IMTX	10.19	0.00	0.43	18424
2025-11-17	IMTX	9.46	0.00	12.50	18555
2025-11-18	IMTX	10.32	0.01	0.00	18707
2025-11-19	IMTX	10.32	0.01	0.00	18698
2025-11-20	IMTX	10.1	0.01	0.00	18809
2025-11-21	IMTX	10.21	0.01	0.00	18809
2025-11-24	IMTX	10.6	0.00	0.00	18442
2025-11-25	IMTX	10.98	0.00	0.00	18443
2025-11-26	IMTX	10.6	0.00	0.00	18445
2025-12-01	IMTX	10.25	0.00	0.00	18467
2025-12-02	IMTX	9.92	0.00	0.00	18485
2025-12-03	IMTX	10.33	0.00	0.00	18485
2025-12-04	IMTX	11.88	0.00	0.01	18487
2025-12-05	IMTX	10.17	0.00	13.16	18562
2025-12-08	IMTX	10.26	0.03	13.67	19092
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-10	IMTX	9.03	-438.4	-	-1.90
2025-11-11	IMTX	9.19	-438.4	-	-1.90
2025-11-12	IMTX	10.68	-438.4	-	-1.90
2025-11-13	IMTX	9.97	-438.4	-	-1.90
2025-11-14	IMTX	10.18	-438.4	-	-1.90
2025-11-17	IMTX	9.46	-438.4	-	-1.90
2025-11-18	IMTX	10.32	-438.4	-	-1.90
2025-11-19	IMTX	10.33	-438.4	-	-1.90
2025-11-20	IMTX	10.10	-204.5	-	-1.90
2025-11-21	IMTX	10.20	-205.0	-	-1.96
2025-11-24	IMTX	10.58	-205.0	-	-1.96
2025-11-25	IMTX	10.97	-205.0	-	-1.96
2025-11-26	IMTX	10.59	-206.1	-	-1.96
2025-12-01	IMTX	10.27	-204.7	-	-1.97
2025-12-02	IMTX	9.89	-204.7	-	-1.97
2025-12-03	IMTX	10.34	-204.7	-	-1.97
2025-12-04	IMTX	11.88	-204.7	-	-1.97
2025-12-05	IMTX	10.18	-204.7	-	-1.97
2025-12-08	IMTX	10.28	-204.8	-	-1.97
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-10	IMTX	0.00	-3.76	4.79
2025-11-11	IMTX	0.00	-3.76	4.79
2025-11-12	IMTX	0.00	-3.76	6.16
2025-11-13	IMTX	0.00	-3.76	6.16
2025-11-14	IMTX	0.00	-3.76	6.13
2025-11-17	IMTX	0.00	1.65	6.13
2025-11-18	IMTX	0.00	1.65	6.13
2025-11-19	IMTX	0.00	1.65	6.13
2025-11-20	IMTX	0.00	1.65	6.13
2025-11-21	IMTX	0.00	1.65	6.11
2025-11-24	IMTX	0.00	-5.06	6.11
2025-11-25	IMTX	0.00	-5.06	6.11
2025-11-26	IMTX	0.00	-5.06	5.86
2025-12-01	IMTX	0.00	-5.06	5.86
2025-12-02	IMTX	0.00	-5.06	5.86
2025-12-03	IMTX	0.00	-5.06	5.86
2025-12-04	IMTX	0.00	-5.06	5.86
2025-12-05	IMTX	0.00	-5.06	5.86
2025-12-08	IMTX	0.00	-5.06	5.86
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-0.49

Avg. EPS Est. Current Quarter

-0.47

Avg. EPS Est. Next Quarter

-0.45

Insider Transactions

Institutional Transactions

-5.06

Beta

1.36

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

44.2

Max Drawdown 5-Year %

-77.4

Target Price

18.37

P/E

Forward P/E

PEG

P/S

13.73

P/B

2.55

P/Free Cash Flow

EPS

-1.09

Average EPS Est. Cur. Y

-1.97

EPS Next Y. (Est.)

-1.83

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-146.11

Relative Volume

0.8

Return on Equity vs Sector %

-54.7

Return on Equity vs Industry %

-39.7

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.07

EBIT Estimation

Immatics N.V.

Sector: Healthcare

Industry: Biotechnology

Employees: 645

Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the research and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as TCR-engineered autologous or allogeneic adoptive cell therapies (ACT) and antibody-like TCR Bispecifics. Its products pipeline includes IMA203 that targets solid tumors, which is in Phase 1b clinical trial; IMA203CD8, a cell therapy product that is in Phase 1b clinical trial; IMA204 that targets tumor stroma, which is in preclinical stage; and IMA30x, an allogenic cellular therapy product candidate, which is in preclinical stage. The company develops TCR Bispecifics products, including IMA401 and IMA402, which is in Phase 1a clinical trial. The company has a strategic collaboration agreement with MD Anderson Cancer Center to develop multiple T cell and TCR-based adoptive cellular therapies; Celgene Corporation to develop novel adoptive cell therapies targeting multiple cancers; and Genmab A/S to develop T cell engaging bispecific immunotherapies targeting multiple cancer indications. Immatics N.V. is headquartered in Tübingen, Germany.

stock quote shares IMTX – Immatics N.V Stock Price stock today

news today IMTX – Immatics N.V stock forecast ,stock prediction 2023 2024 2025

marketwatch IMTX – Immatics N.V yahoo finance google finance

stock history IMTX – Immatics N.V invest stock market

stock prices IMTX premarket after hours

ticker IMTX fair value insiders trading

FMS – Fresenius Medical Care AG ADR

Float Short %

0.13

Margin Of Safety %

Put/Call OI Ratio

0.41

EPS Next Q Diff

-0.15

EPS Last/This Y

1.52

EPS This/Next Y

0.36

Price

22.83

Target Price

27.12

Analyst Recom

2.9

Performance Q

-9.76

Relative Volume

0.9

Beta

0.89

Ticker: FMS

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-10	FMS	23.69	0.40	999.99	2952
2025-11-11	FMS	23.99	0.40	999.99	2952
2025-11-12	FMS	23.95	0.40	999.99	2952
2025-11-13	FMS	23.69	0.41	999.99	2967
2025-11-14	FMS	23.4	0.41	999.99	2967
2025-11-17	FMS	23.02	0.42	999.99	2978
2025-11-18	FMS	22.94	0.42	999.99	2978
2025-11-19	FMS	22.79	0.42	1.00	2978
2025-11-20	FMS	22.59	0.42	0.14	2980
2025-11-21	FMS	23.41	0.42	0.00	2979
2025-11-24	FMS	23.76	0.42	0.00	2979
2025-11-25	FMS	24.07	0.41	0.00	2936
2025-11-26	FMS	23.82	0.41	0.00	2936
2025-12-01	FMS	23.65	0.41	0.00	2946
2025-12-02	FMS	23.75	0.41	0.00	2946
2025-12-03	FMS	23.57	0.41	999.99	2946
2025-12-04	FMS	23.35	0.41	999.99	2946
2025-12-05	FMS	23.26	0.41	999.99	2946
2025-12-08	FMS	22.84	0.41	999.99	2946
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-10	FMS	23.70	-32.3	1003.2	1.75
2025-11-11	FMS	23.99	-32.3	1041.4	1.89
2025-11-12	FMS	23.94	-32.3	1018.9	1.89
2025-11-13	FMS	23.71	-32.3	1002.8	1.89
2025-11-14	FMS	23.39	-32.3	997.5	1.89
2025-11-17	FMS	23.03	-32.3	990.4	2.32
2025-11-18	FMS	22.94	7.5	1011.3	2.32
2025-11-19	FMS	22.79	7.5	1005.3	2.32
2025-11-20	FMS	22.59	7.0	1017.9	2.31
2025-11-21	FMS	23.41	7.0	1093.4	2.31
2025-11-24	FMS	23.75	7.0	1058.3	2.31
2025-11-25	FMS	24.06	7.0	1057.5	2.31
2025-11-26	FMS	23.83	7.0	1017.4	2.31
2025-12-01	FMS	23.64	7.0	1004.4	2.31
2025-12-02	FMS	23.73	7.0	1028.2	2.31
2025-12-03	FMS	23.57	7.0	1011.7	2.31
2025-12-04	FMS	23.36	7.0	982.6	2.31
2025-12-05	FMS	23.25	7.0	986.2	2.58
2025-12-08	FMS	22.83	7.0	-	2.58
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-10	FMS	0	1.00	0.11
2025-11-11	FMS	0	1.00	0.11
2025-11-12	FMS	0	1.00	0.29
2025-11-13	FMS	0	1.00	0.29
2025-11-14	FMS	0	1.00	0.29
2025-11-17	FMS	0	0.95	0.29
2025-11-18	FMS	0	0.95	0.29
2025-11-19	FMS	0	0.95	0.29
2025-11-20	FMS	0	0.95	0.29
2025-11-21	FMS	0	0.95	0.29
2025-11-24	FMS	0	0.13	0.29
2025-11-25	FMS	0.00	0.13	0.29
2025-11-26	FMS	0.00	0.13	0.13
2025-12-01	FMS	0.00	0.17	0.13
2025-12-02	FMS	0.00	0.17	0.13
2025-12-03	FMS	0.00	0.17	0.13
2025-12-04	FMS	0.00	0.17	0.13
2025-12-05	FMS	0.00	0.17	0.13
2025-12-08	FMS	0.00	0.19	0.13
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

0.64

Avg. EPS Est. Current Quarter

0.49

Avg. EPS Est. Next Quarter

0.49

Insider Transactions

Institutional Transactions

0.19

Beta

0.89

Average Sales Estimate Current Quarter

4740

Average Sales Estimate Next Quarter

4938

Fair Value

29.06

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

47.3

Max Drawdown 5-Year %

-69.1

Target Price

27.12

P/E

16.57

Forward P/E

9.4

PEG

0.85

P/S

0.61

P/B

0.87

P/Free Cash Flow

6.66

EPS

1.38

Average EPS Est. Cur. Y

2.58

EPS Next Y. (Est.)

2.94

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

3.72

Relative Volume

0.9

Return on Equity vs Sector %

-21.3

Return on Equity vs Industry %

-113.1

EPS 1 7Days Diff

0.3

EPS 1 30Days Diff

0.69

EBIT Estimation

Fresenius Medical Care AG

Sector: Healthcare

Industry: Medical Care Facilities

Employees: 109916

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments. It also develops, manufactures, and distributes various health care products, including hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular specialty, ambulatory surgery center, physician nephrology practice management, ambulant treatment, pharmacy and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

stock quote shares FMS – Fresenius Medical Care AG ADR Stock Price stock today

news today FMS – Fresenius Medical Care AG ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch FMS – Fresenius Medical Care AG ADR yahoo finance google finance

stock history FMS – Fresenius Medical Care AG ADR invest stock market

stock prices FMS premarket after hours

ticker FMS fair value insiders trading

FMS – Fresenius Medical Care AG & Co. KGaA

Float Short %

0.13

Margin Of Safety %

Put/Call OI Ratio

0.41

EPS Next Q Diff

-0.15

EPS Last/This Y

1.52

EPS This/Next Y

0.36

Price

22.83

Target Price

27.12

Analyst Recom

2.9

Performance Q

-9.76

Relative Volume

0.9

Beta

0.89

Ticker: FMS

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-10	FMS	23.69	0.40	999.99	2952
2025-11-11	FMS	23.99	0.40	999.99	2952
2025-11-12	FMS	23.95	0.40	999.99	2952
2025-11-13	FMS	23.69	0.41	999.99	2967
2025-11-14	FMS	23.4	0.41	999.99	2967
2025-11-17	FMS	23.02	0.42	999.99	2978
2025-11-18	FMS	22.94	0.42	999.99	2978
2025-11-19	FMS	22.79	0.42	1.00	2978
2025-11-20	FMS	22.59	0.42	0.14	2980
2025-11-21	FMS	23.41	0.42	0.00	2979
2025-11-24	FMS	23.76	0.42	0.00	2979
2025-11-25	FMS	24.07	0.41	0.00	2936
2025-11-26	FMS	23.82	0.41	0.00	2936
2025-12-01	FMS	23.65	0.41	0.00	2946
2025-12-02	FMS	23.75	0.41	0.00	2946
2025-12-03	FMS	23.57	0.41	999.99	2946
2025-12-04	FMS	23.35	0.41	999.99	2946
2025-12-05	FMS	23.26	0.41	999.99	2946
2025-12-08	FMS	22.84	0.41	999.99	2946
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-10	FMS	23.70	-32.3	1003.2	1.75
2025-11-11	FMS	23.99	-32.3	1041.4	1.89
2025-11-12	FMS	23.94	-32.3	1018.9	1.89
2025-11-13	FMS	23.71	-32.3	1002.8	1.89
2025-11-14	FMS	23.39	-32.3	997.5	1.89
2025-11-17	FMS	23.03	-32.3	990.4	2.32
2025-11-18	FMS	22.94	7.5	1011.3	2.32
2025-11-19	FMS	22.79	7.5	1005.3	2.32
2025-11-20	FMS	22.59	7.0	1017.9	2.31
2025-11-21	FMS	23.41	7.0	1093.4	2.31
2025-11-24	FMS	23.75	7.0	1058.3	2.31
2025-11-25	FMS	24.06	7.0	1057.5	2.31
2025-11-26	FMS	23.83	7.0	1017.4	2.31
2025-12-01	FMS	23.64	7.0	1004.4	2.31
2025-12-02	FMS	23.73	7.0	1028.2	2.31
2025-12-03	FMS	23.57	7.0	1011.7	2.31
2025-12-04	FMS	23.36	7.0	982.6	2.31
2025-12-05	FMS	23.25	7.0	986.2	2.58
2025-12-08	FMS	22.83	7.0	-	2.58
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-10	FMS	0	1.00	0.11
2025-11-11	FMS	0	1.00	0.11
2025-11-12	FMS	0	1.00	0.29
2025-11-13	FMS	0	1.00	0.29
2025-11-14	FMS	0	1.00	0.29
2025-11-17	FMS	0	0.95	0.29
2025-11-18	FMS	0	0.95	0.29
2025-11-19	FMS	0	0.95	0.29
2025-11-20	FMS	0	0.95	0.29
2025-11-21	FMS	0	0.95	0.29
2025-11-24	FMS	0	0.13	0.29
2025-11-25	FMS	0.00	0.13	0.29
2025-11-26	FMS	0.00	0.13	0.13
2025-12-01	FMS	0.00	0.17	0.13
2025-12-02	FMS	0.00	0.17	0.13
2025-12-03	FMS	0.00	0.17	0.13
2025-12-04	FMS	0.00	0.17	0.13
2025-12-05	FMS	0.00	0.17	0.13
2025-12-08	FMS	0.00	0.19	0.13
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

0.64

Avg. EPS Est. Current Quarter

0.49

Avg. EPS Est. Next Quarter

0.49

Insider Transactions

Institutional Transactions

0.19

Beta

0.89

Average Sales Estimate Current Quarter

4740

Average Sales Estimate Next Quarter

4938

Fair Value

29.06

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

47.3

Max Drawdown 5-Year %

-69.1

Target Price

27.12

P/E

16.57

Forward P/E

9.4

PEG

0.85

P/S

0.61

P/B

0.87

P/Free Cash Flow

6.66

EPS

1.38

Average EPS Est. Cur. Y

2.58

EPS Next Y. (Est.)

2.94

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

3.72

Relative Volume

0.9

Return on Equity vs Sector %

-21.3

Return on Equity vs Industry %

-113.1

EPS 1 7Days Diff

0.3

EPS 1 30Days Diff

0.69

EBIT Estimation

Fresenius Medical Care AG

Sector: Healthcare

Industry: Medical Care Facilities

Employees: 109916

stock quote shares FMS – Fresenius Medical Care AG & Co. KGaA Stock Price stock today

news today FMS – Fresenius Medical Care AG & Co. KGaA stock forecast ,stock prediction 2023 2024 2025

marketwatch FMS – Fresenius Medical Care AG & Co. KGaA yahoo finance google finance

stock history FMS – Fresenius Medical Care AG & Co. KGaA invest stock market

stock prices FMS premarket after hours

ticker FMS fair value insiders trading

SSU – SIGNA Sports United N.V.

Float Short %

0.16

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

0.02

Target Price

3.92

Analyst Recom

3.5

Performance Q

-96.71

Relative Volume

Beta

0.55

Ticker: SSU

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-10	SSU	0.0937	N/A	N/A	0
2025-11-11	SSU	0.0937	N/A	N/A	0
2025-11-12	SSU	0.0937	N/A	N/A	0
2025-11-13	SSU	0.0937	N/A	N/A	0
2025-11-14	SSU	0.0937	N/A	N/A	0
2025-11-17	SSU	0.0937	N/A	N/A	0
2025-11-18	SSU	0.0937	N/A	N/A	0
2025-11-19	SSU	0.0937	N/A	N/A	0
2025-11-20	SSU	0.0937	N/A	N/A	0
2025-11-21	SSU	0.0937	N/A	N/A	0
2025-11-24	SSU	0.0937	N/A	N/A	0
2025-11-25	SSU	0.0937	N/A	N/A	0
2025-11-26	SSU	0.0937	N/A	N/A	0
2025-12-01	SSU	0.0937	N/A	N/A	0
2025-12-02	SSU	0.0937	N/A	N/A	0
2025-12-03	SSU	0.0937	N/A	N/A	0
2025-12-04	SSU	0.0937	N/A	N/A	0
2025-12-05	SSU	0.0937	N/A	N/A	0
2025-12-08	SSU	0.0937	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

0.55

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

99.8

Max Drawdown 5-Year %

Target Price

3.92

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

-1.08

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

-137

Return on Equity vs Industry %

-170

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

stock quote shares SSU – SIGNA Sports United N.V. Stock Price stock today

news today SSU – SIGNA Sports United N.V. stock forecast ,stock prediction 2023 2024 2025

marketwatch SSU – SIGNA Sports United N.V. yahoo finance google finance

stock history SSU – SIGNA Sports United N.V. invest stock market

stock prices SSU premarket after hours

ticker SSU fair value insiders trading

SAP – SAP SE

Float Short %

0.15

Margin Of Safety %

Put/Call OI Ratio

0.9

EPS Next Q Diff

0.04

EPS Last/This Y

3.81

EPS This/Next Y

1.51

Price

242.98

Target Price

342.1

Analyst Recom

1.62

Performance Q

-10.5

Relative Volume

1.05

Beta

1.18

Ticker: SAP

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-10	SAP	251.68	1.04	0.66	35972
2025-11-11	SAP	254.41	1.05	1.37	36310
2025-11-12	SAP	253.33	1.02	1.91	36596
2025-11-13	SAP	251.86	1.00	3.12	36429
2025-11-14	SAP	244.98	0.99	1.57	36182
2025-11-17	SAP	238.96	0.97	1.81	36736
2025-11-18	SAP	238	0.94	0.80	36873
2025-11-19	SAP	237.99	0.91	2.69	37335
2025-11-20	SAP	233.96	0.92	11.23	37794
2025-11-21	SAP	236.7	0.87	1.72	37532
2025-11-24	SAP	238.3	1.05	0.48	29875
2025-11-25	SAP	237.83	1.03	1.23	30255
2025-11-26	SAP	240.03	1.03	0.68	30410
2025-12-01	SAP	242.06	1.01	0.62	30559
2025-12-02	SAP	241.63	1.00	1.11	31602
2025-12-03	SAP	243.81	1.00	0.13	31286
2025-12-04	SAP	245.54	0.90	0.46	33073
2025-12-05	SAP	247.16	0.90	0.77	33367
2025-12-08	SAP	242.96	0.90	1.54	33573
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-10	SAP	251.76	18.6	580.6	6.94
2025-11-11	SAP	254.38	18.6	721.0	6.94
2025-11-12	SAP	253.33	18.6	721.0	6.94
2025-11-13	SAP	251.85	18.6	557.7	6.94
2025-11-14	SAP	244.99	18.6	193.0	6.94
2025-11-17	SAP	238.77	18.6	301.6	6.94
2025-11-18	SAP	238.05	18.6	521.6	6.94
2025-11-19	SAP	237.97	18.6	563.6	6.94
2025-11-20	SAP	233.92	18.6	492.6	6.94
2025-11-21	SAP	236.76	18.6	572.8	6.94
2025-11-24	SAP	238.29	18.6	764.2	6.94
2025-11-25	SAP	237.86	18.4	576.0	6.93
2025-11-26	SAP	240.07	18.4	856.2	6.93
2025-12-01	SAP	242.08	18.4	725.9	6.93
2025-12-02	SAP	241.72	18.4	683.1	6.93
2025-12-03	SAP	243.82	18.4	820.8	6.93
2025-12-04	SAP	245.49	18.4	841.0	6.93
2025-12-05	SAP	247.26	18.4	940.4	6.93
2025-12-08	SAP	242.98	18.4	-	6.93
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-10	SAP	0	0.02	0.27
2025-11-11	SAP	0	0.02	0.27
2025-11-12	SAP	0	0.02	0.17
2025-11-13	SAP	0	0.02	0.17
2025-11-14	SAP	0	0.02	0.17
2025-11-17	SAP	0	-0.08	0.17
2025-11-18	SAP	0.00	-0.08	0.17
2025-11-19	SAP	0	-0.08	0.17
2025-11-20	SAP	0	-0.08	0.17
2025-11-21	SAP	0	-0.08	0.17
2025-11-24	SAP	0	0.09	0.17
2025-11-25	SAP	0	0.09	0.17
2025-11-26	SAP	0	0.09	0.15
2025-12-01	SAP	0	0.11	0.15
2025-12-02	SAP	0	0.11	0.15
2025-12-03	SAP	0	0.11	0.15
2025-12-04	SAP	0	0.11	0.15
2025-12-05	SAP	0	0.11	0.15
2025-12-08	SAP	0	-0.00	0.15
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

1.86

Avg. EPS Est. Current Quarter

1.74

Avg. EPS Est. Next Quarter

1.9

Insider Transactions

Institutional Transactions

Beta

1.18

Average Sales Estimate Current Quarter

9768

Average Sales Estimate Next Quarter

9749

Fair Value

293.94

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

22.4

Max Drawdown 5-Year %

-46.1

Target Price

342.1

P/E

36.39

Forward P/E

29.13

PEG

1.3

P/S

6.86

P/B

5.5

P/Free Cash Flow

38.41

EPS

6.68

Average EPS Est. Cur. Y

6.93

EPS Next Y. (Est.)

8.44

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

19.46

Relative Volume

1.05

Return on Equity vs Sector %

-36.2

Return on Equity vs Industry %

-4.3

EPS 1 7Days Diff

EPS 1 30Days Diff

0.02

EBIT Estimation

SAP SE

Sector: Technology

Industry: Software - Application

Employees: 110730

SAP SE, together with its subsidiaries, provides enterprise application and business solutions worldwide. It offers SAP S/4HANA that provides software capabilities for finance, risk and project management, procurement, manufacturing, supply chain and asset management, and research and development; SAP SuccessFactors solutions for human resources, including HR, time, payroll, talent and employee experience management, and analytics and planning; and spend management solutions that covers direct and indirect spend, travel and expense, and external workforce management. The company also provides SAP customer experience solutions; SAP Business Technology platform that enables customers and partners to build, integrate, and automate applications; and SAP Business Network, a business-to-business collaboration platform that helps digitalize key business processes across the supply chain and enables communication between trading partners. In addition, it offers SAP Signavio to help customers to discover, analyze, and understand their business process operations; industry solutions that provides customers and partners with industry-specific solutions; and SAP LeanIX to visualize their as-is enterprise architecture, assess interdependencies and the potential impact of IT modernization, and manage the transition toward the target landscape with established practices and a detailed roadmap. Further, the company provides WalkMe to execute workflows across various number of applications; SAP Enable Now, which offers e-learning content embedded in SAP workflows; Taulia solutions for working capital management to help businesses create and deliver the right cash flow strategy, and the flexibility to adjust it to meet liquidity challenges; and sustainability solutions and services. Additionally, it provides services and support solutions. SAP SE was founded in 1972 and is headquartered in Walldorf, Germany.

stock quote shares SAP – SAP SE Stock Price stock today

news today SAP – SAP SE stock forecast ,stock prediction 2023 2024 2025

marketwatch SAP – SAP SE yahoo finance google finance

stock history SAP – SAP SE invest stock market

stock prices SAP premarket after hours

ticker SAP fair value insiders trading

No more stocks to show

VJET – Voxeljet AG ADR

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: VJET

No data found

No data found

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

IMTX – Immatics N.V

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: IMTX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y